Clinical trial
Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma
NCT00398554 · Christine Mauz-Körholz, Other · Completed
Key facts
| NCT number | NCT00398554 |
|---|---|
| Title | Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma |
| Official title | Pilot Study for Therapy Optimising for Hodgkin's Lymphoma in Childhood and Adolescence; Optimising Therapy for Boys With Hodgkin's Lymphoma in Intermediate and Advanced Stages. Safety and Efficacy Study for Drug Combination VECOPA |
| Lead sponsor | Christine Mauz-Körholz, Other |
| Collaborators | Martin-Luther-Universität Halle-Wittenberg |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug, Radiation |
| Interventions | cyclophosphamide, doxorubicin hydrochloride, etoposide, prednisone, vinblastine sulfate, vincristine sulfate, radiation therapy |
| Enrollment | 16 |
| Start date | Jun 1, 2005 |
| Primary completion | Oct 1, 2012 |
| Completion | Mar 1, 2013 |
| First posted | Nov 10, 2006 |
| Last update posted | Mar 26, 2020 |
| Countries | Germany, Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: